BioCentury | Jan 14, 2013
Clinical News

PHT101 regulatory update

...clinical testing of PHT101 this year or next year. The partners discovered PHT101, which uses PharmaIN's...
...worldwide rights to products resulting from the deal, is responsible for clinical development and marketing. PharmaIn...
BioCentury | May 10, 2004
Finance

Midwest work ethic

...Orion to develop its cancer diagnostics, which are the second leg of its business plan. PharmaIn...
BioCentury | Feb 2, 2004
Company News

PharmaIn board of directors update

PharmaIn Ltd. , Buffalo Grove, Ill. Business: Drug delivery Appointed: James Foght, chairman at IllinoisVentures LLC, as chairman WIR Staff...
Items per page:
1 - 3 of 3
BioCentury | Jan 14, 2013
Clinical News

PHT101 regulatory update

...clinical testing of PHT101 this year or next year. The partners discovered PHT101, which uses PharmaIN's...
...worldwide rights to products resulting from the deal, is responsible for clinical development and marketing. PharmaIn...
BioCentury | May 10, 2004
Finance

Midwest work ethic

...Orion to develop its cancer diagnostics, which are the second leg of its business plan. PharmaIn...
BioCentury | Feb 2, 2004
Company News

PharmaIn board of directors update

PharmaIn Ltd. , Buffalo Grove, Ill. Business: Drug delivery Appointed: James Foght, chairman at IllinoisVentures LLC, as chairman WIR Staff...
Items per page:
1 - 3 of 3